Sera Prognostics Inc (NASDAQ: SERA) — Healthcare · Share Price, Chart & Market Data
About: Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Sector: Healthcare
Industry: Medical Devices
Latest price: $2.01 (-5.19%)
SERASera Prognostics Inc
Loading watchlist status…
Trade SERA now
Sera Prognostics Inc share price
SERA price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 7:27 am GMT+0
SERA price performance
-12.227%
5D
-0.985%
1M
-33%
YTD
-40%
1Y
SERA price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 7:27 am GMT+0
SERA details
SERA Market Signals